Spots Global Cancer Trial Database for recurrent cervical cancer

Every month we try and update this database with for recurrent cervical cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
FDG-PET and Circulating HPV in Patients With Cervical Cancer	NCT02388698	Cervical Cancer	Cervical swab PET-CT Plasma HPV	18 Years -	Sunnybrook Health Sciences Centre
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer	NCT03367871	Cervical Cancer	Pembrolizumab Paclitaxel Cisplatin Carboplatin Bevacizumab	18 Years -	University of Miami
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer	NCT01676818	Recurrent Cervi... Stage IIIA Cerv... Stage IIIB Cerv... Stage IVA Cervi... Stage IVB Cervi...	eribulin mesyla...	18 Years -	University of Southern California
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers	NCT01846520	Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung...	educational int... telephone-based... quality-of-life... questionnaire a...	18 Years -	City of Hope Medical Center
DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix	NCT00004866	Cervical Cancer	exatecan mesyla...	18 Years -	Daiichi Sankyo
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer	NCT00003135	Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer	fluorouracil pegylated lipos... hyperthermia tr...	18 Years -	National Cancer Institute (NCI)
Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer	NCT02849340	Recurrent Cervi...	Cryosurgery NK immunotherap...	30 Years - 70 Years	Fuda Cancer Hospital, Guangzhou
Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	NCT00691301	Cervical Cancer	cisplatin pemetrexed diso...	- 120 Years	GOG Foundation
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors	NCT00066651	Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton...	SS1(dsFv)-PE38 ...	18 Years -	National Cancer Institute (NCI)
Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer	NCT00462397	Cervical Cancer	carboplatin cisplatin paclitaxel neoadjuvant the... brachytherapy radiation thera...	18 Years -	National Cancer Institute (NCI)
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer	NCT00287885	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... Sarcoma Vaginal Cancer Vulvar Cancer	docetaxel	18 Years -	Masonic Cancer Center, University of Minnesota
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer	NCT00002813	Cervical Cancer	cisplatin vinorelbine tar...	-	GOG Foundation
Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	NCT00101192	Cervical Cancer	cetuximab cisplatin	18 Years -	GOG Foundation
Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix	NCT00031993	Cervical Squamo... Recurrent Cervi...	erlotinib hydro... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	NCT00101192	Cervical Cancer	cetuximab cisplatin	18 Years -	GOG Foundation
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma	NCT00082823	Cancer	ziv-aflibercept	18 Years - 120 Years	Regeneron Pharmaceuticals
Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva	NCT00003525	Cervical Cancer... Vulvar Cancer, ...	Antineoplaston ...	18 Years - 99 Years	Burzynski Research Institute
the Re-irradiation of Recurrent Cervical Cancer by IMRT	NCT03170570	Cervical Cancer Radiation Toxic... Recurrent Cervi...	intensity-modul...	18 Years - 65 Years	Sun Yat-sen University
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity	NCT00003548	Cancer	aminocamptothec...	18 Years -	NYU Langone Health
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Dostarlimab and Cobolimab in Advanced Cervical Cancer	NCT06238635	Cervical Cancer Advanced Cervic... Metastatic Cerv... Metastatic Cerv... Recurrent Cervi...	Dostarlimab Cobolimab	18 Years -	Beth Israel Deaconess Medical Center
S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer	NCT00003369	Cervical Cancer	cisplatin tirapazamine	18 Years -	SWOG Cancer Research Network
Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer	NCT00978874	Cervical Cancer	fludeoxyglucose... fluorine F 18 E...	18 Years - 120 Years	Abramson Cancer Center at Penn Medicine
Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery	NCT01229930	Cervical Cancer	carboplatin cediranib malea... paclitaxel laboratory biom... pharmacological... quality-of-life...	18 Years -	National Cancer Institute (NCI)
Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer	NCT04230954	Cervical Cancer Recurrent Cervi... Metastatic Cerv... Persistent Cerv...	Cabozantinib 40... Pembrolizumab 2...	18 Years -	University of South Alabama
Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer	NCT00138151	Cervical Cancer	recombinant int... isotretinoin paclitaxel	18 Years -	Rutgers, The State University of New Jersey
Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	NCT00016926	Cervical Cancer	capecitabine	-	GOG Foundation
S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer	NCT00003369	Cervical Cancer	cisplatin tirapazamine	18 Years -	SWOG Cancer Research Network
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma	NCT00004261	Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma	EF5 flow cytometry fluorescent ant... immunohistochem... biopsy	18 Years - 120 Years	University Health Network, Toronto
SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer	NCT00026260	Cervical Cancer	semaxanib	-	National Cancer Institute (NCI)
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer	NCT01313104	Cervical Intrae... Cervical Intrae... Cervical Intrae... Recurrent Cervi... Recurrent Vagin... Recurrent Vulva... Stage 0 Cervica... Stage 0 Vaginal... Stage 0 Vulvar ... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IB Cervic... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Vagin... Stage III Vulva... Stage IV Vulvar... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin...	colposcopy cervical Papani... screening metho... screening metho...	18 Years -	Northwestern University
CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer	NCT00610740	Cervical Cancer Endometrial Can... Ovarian Cancer	topical gemcita... therapeutic con...	18 Years -	Masonic Cancer Center, University of Minnesota
Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer	NCT00019084	Breast Cancer Cervical Cancer Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc...	aldesleukin mutant p53 pept... ras peptide can... sargramostim therapeutic aut... therapeutic tum...	18 Years -	National Cancer Institute (NCI)
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer	NCT00118300	Cervical Cancer Endometrial Can... Ovarian Cancer Vaginal Cancer	capecitabine brachytherapy radiation thera...	18 Years -	Case Comprehensive Cancer Center
Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies	NCT00335998	Recurrent Cervi... Recurrent Ovari... Recurrent Vagin... Recurrent Vulva... Stage III Vagin... Stage IIIA Cerv... Stage IIIA Ovar... Stage IIIA Vulv... Stage IIIB Cerv... Stage IIIB Ovar... Stage IIIB Vulv... Stage IIIC Ovar... Stage IIIC Vulv... Stage IV Ovaria... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin...	triapine laboratory biom... external beam r... brachytherapy cisplatin pharmacological...	18 Years -	National Cancer Institute (NCI)
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer	NCT01313104	Cervical Intrae... Cervical Intrae... Cervical Intrae... Recurrent Cervi... Recurrent Vagin... Recurrent Vulva... Stage 0 Cervica... Stage 0 Vaginal... Stage 0 Vulvar ... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IB Cervic... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Vagin... Stage III Vulva... Stage IV Vulvar... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin...	colposcopy cervical Papani... screening metho... screening metho...	18 Years -	Northwestern University
Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer	NCT00941070	Recurrent Cervi... Recurrent Vagin... Stage IB Cervic... Stage II Vagina... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Vagin... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... Therapy-related...	triapine cisplatin external beam r... quality-of-life... questionnaire a... fludeoxyglucose... positron emissi... computed tomogr...	18 Years -	National Cancer Institute (NCI)
A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer	NCT02172911	Cervical Cancer	INO-3112 CELLECTRA™-5P	18 Years -	Inovio Pharmaceuticals
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer	NCT01764789	Anxiety Disorde... Depression Fatigue Leydig Cell Tum... Ovarian Sarcoma Ovarian Stromal... Pain Peritoneal Carc... Pseudomyxoma Pe... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Fallo... Recurrent Gesta... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Recurrent Vagin... Recurrent Vulva...	questionnaire a... quality-of-life... psychosocial as... behavioral inte... cognitive inter... educational int...	21 Years - 85 Years	Ohio State University Comprehensive Cancer Center
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer	NCT00003704	Cancer	capecitabine radiation thera...	18 Years -	Alliance for Clinical Trials in Oncology
Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer	NCT00005837	Cervical Cancer	oxaliplatin	-	National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma	NCT00101972	Cancer	monoclonal anti...	18 Years -	MacroGenics
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer	NCT00005941	Cervical Cancer Vaginal Cancer	therapeutic all... cyclosporine fludarabine pho... mycophenolate m... peripheral bloo... radiation thera...	- 64 Years	Fred Hutchinson Cancer Center
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer	NCT00032162	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma	carboplatin pegylated lipos...	18 Years -	AGO Study Group
PET Scans in Diagnosing Primary or Recurrent Cervical Cancer in Patients Who Are Undergoing Surgery	NCT00003429	Cervical Cancer	biopsy computed tomogr... positron emissi... fludeoxyglucose...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Phase II Study of Pazopanib and Topotecan in Cervical Cancer	NCT02348398	Cervical Cancer	Pazopanib Topotecan Phone Call	18 Years -	M.D. Anderson Cancer Center
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen	NCT00016380	Cancer	dexamethasone ondansetron quality-of-life...	16 Years - 120 Years	Canadian Cancer Trials Group
Immunotoxin Therapy in Treating Patients With Advanced Cancer	NCT00006981	Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton...	SS1(dsFv)-PE38 ...	18 Years -	National Cancer Institute (NCI)
Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer	NCT00002478	Cervical Cancer Ovarian Cancer	etoposide	-	GOG Foundation
Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer	NCT02849340	Recurrent Cervi...	Cryosurgery NK immunotherap...	30 Years - 70 Years	Fuda Cancer Hospital, Guangzhou
Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	NCT00276796	Cervical Cancer	cisplatin paclitaxel topotecan hydro...	18 Years -	GOG Foundation
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Dostarlimab and Cobolimab in Advanced Cervical Cancer	NCT06238635	Cervical Cancer Advanced Cervic... Metastatic Cerv... Metastatic Cerv... Recurrent Cervi...	Dostarlimab Cobolimab	18 Years -	Beth Israel Deaconess Medical Center
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer	NCT00003135	Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer	fluorouracil pegylated lipos... hyperthermia tr...	18 Years -	National Cancer Institute (NCI)
Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer	NCT00807079	Cervical Cancer	carboplatin topotecan hydro...	18 Years -	ARCAGY/ GINECO GROUP
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma	NCT00083213	Cancer	ziv-aflibercept	18 Years - 120 Years	Regeneron Pharmaceuticals
First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer	NCT04974944	Stage IVB Cervi... Recurrent Cervi... Persistent Cerv...	Camrelizumab Apatinib Paclitaxel Cisplatin Carboplatin Bevacizumab	18 Years - 70 Years	Sun Yat-sen University
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer	NCT01313104	Cervical Intrae... Cervical Intrae... Cervical Intrae... Recurrent Cervi... Recurrent Vagin... Recurrent Vulva... Stage 0 Cervica... Stage 0 Vaginal... Stage 0 Vulvar ... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IB Cervic... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Vagin... Stage III Vulva... Stage IV Vulvar... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin...	colposcopy cervical Papani... screening metho... screening metho...	18 Years -	Northwestern University
Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.	NCT00258401	Cervical Cancer Diarrhea Prostate Cancer Radiation Toxic... Sarcoma	dietary interve... management of t... quality-of-life...	20 Years - 80 Years	Case Comprehensive Cancer Center
Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.	NCT00258401	Cervical Cancer Diarrhea Prostate Cancer Radiation Toxic... Sarcoma	dietary interve... management of t... quality-of-life...	20 Years - 80 Years	Case Comprehensive Cancer Center
Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	NCT00276796	Cervical Cancer	cisplatin paclitaxel topotecan hydro...	18 Years -	GOG Foundation
H101 Combined With Camrelizumab for Recurrent Cervical Cancer	NCT05234905	Uterine Cervica... Oncolytic Virot... Camrelizumab	Recombinant hum...	18 Years - 80 Years	Zhejiang Cancer Hospital
Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers	NCT00545792	Cervical Cancer Endometrial Can... Ovarian Cancer Vaginal Cancer Carcinoma of th...	Avastin	18 Years -	Dana-Farber Cancer Institute
S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer	NCT00057928	Cervical Cancer	cisplatin gemcitabine hyd... paclitaxel	-	SWOG Cancer Research Network
A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer	NCT04380805	Recurrent Cervi... Metastatic Cerv...	AK104	18 Years -	Akeso
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer	NCT00003704	Cancer	capecitabine radiation thera...	18 Years -	Alliance for Clinical Trials in Oncology
Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer	NCT02849340	Recurrent Cervi...	Cryosurgery NK immunotherap...	30 Years - 70 Years	Fuda Cancer Hospital, Guangzhou
Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	NCT00691301	Cervical Cancer	cisplatin pemetrexed diso...	- 120 Years	GOG Foundation
S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer	NCT00057928	Cervical Cancer	cisplatin gemcitabine hyd... paclitaxel	-	SWOG Cancer Research Network
Immunotoxin Therapy in Treating Patients With Advanced Cancer	NCT00006981	Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton...	SS1(dsFv)-PE38 ...	18 Years -	National Cancer Institute (NCI)
CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer	NCT00610740	Cervical Cancer Endometrial Can... Ovarian Cancer	topical gemcita... therapeutic con...	18 Years -	Masonic Cancer Center, University of Minnesota
Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer	NCT00005999	Cervical Cancer	arsenic trioxid...	17 Years -	National Cancer Institute (NCI)
Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva	NCT00003525	Cervical Cancer... Vulvar Cancer, ...	Antineoplaston ...	18 Years - 99 Years	Burzynski Research Institute
the Re-irradiation of Recurrent Cervical Cancer by IMRT	NCT03170570	Cervical Cancer Radiation Toxic... Recurrent Cervi...	intensity-modul...	18 Years - 65 Years	Sun Yat-sen University
Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer	NCT00087126	Cervical Cancer	topotecan hydro...	18 Years - 120 Years	GOG Foundation
Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer	NCT00003977	Cervical Cancer	human papilloma... in vitro-treate...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: